OOIR: Observatory of International Research

Papers

(The TQCC of Best Practice & Research Clinical Endocrinology & Metabolism is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Editorial Board	145
Editorial Board	85
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	73
Editorial Board	69
Thiazide-induced hyponatremia	66
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	60
Surgery for prolactinoma	59
Gonadectomy in individuals with a difference of sex development – For whom, when, why, and why not?	57
The novel concept of “Onco-Immuno-Endocrinology” led to the discovery of new clinical entity “paraneoplastic autoimmune hypophysitis”	53
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	52
The role of androgens in transgender medicine	45
Sexual health and contraception in the menopause journey	42
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation	41
Coronavirus disease 2019 and vitamin D	39
Immune checkpoint inhibitor-related thyroid dysfunction	35
Editorial Board	35
Impulse control disorders and dopamine agonists	33
Editorial Board	32
Haematological actions of androgens	31
Cardiometabolic outcomes of early onset hypogonadism in males	31
Remnant lipoprotein particles and cardiovascular disease risk	31
Editorial Board	30
Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications	30
Type 1 diabetes related to immune checkpoint inhibitors	29
Radioiodine therapy in the different stages of differentiated thyroid cancer	27

Medullary thyroid cancer - An update	27
Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis	27
Epidemiology and risk factors for hypopituitarism due to traumatic brain injury	27
Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia	25
Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk	25
Non-oestrogen-based and complementary therapies for menopause	25
Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms	25
Approach to patients with elevated low-density lipoprotein cholesterol levels	24
Metabolic complications and their mechanisms in patients with craniopharyngioma	24
Immune checkpoint inhibitor-related hypophysitis	23
Pathophysiology of thyroid-associated orbitopathy	23
Best practice and research clinical endocrinology and metabolism issue on phaeochromocytomas and paragangliomas	22
Editorial Board	22
Editorial Board	22
Onco-immuno-endocrinology: An emerging concept that links tumor, autoimmunity, and endocrine disease	22
Safety of androgen therapy in men with prostate cancer	21
Pathophysiology and diagnosis of neuroendocrine abnormalities in patients with traumatic brain injury	21
Hyponatraemic encephalopathy	20
History of androgens and androgen action	20
Editorial Board	19
Best Practice and Research Clinical Endocrinology and Metabolism focusing on Growth Hormone Deficiency in Adults – New Perspectives	19
Localization in primary hyperparathyroidism	19
Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery	19
Personalized management for phaeochromocytomas and paragangliomas in Latin America: A genetic perspective	19
Hyponatremia and bone pathophysiology: An integrated preclinical and clinical perspective	18
Editorial Board	18
Post cancer care in women with an increased risk of malignancy or previous malignancy: The use of hormone replacement therapy and alternative treatments	17
Recent advances in algorithms predicting hemodynamic instability undergoing surgery for phaeochromocytoma and paraganglioma	16
Editorial Board	16
Diagnostic algorithm of hyponatremia	15
Diagnosis and treatment of hypernatremia	14
Preface	14
Anaplastic thyroid cancer: An update	14
Hormone replacement in disorders of sex development, and long-term effects	14
Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment	14
Best practice & research clinical endocrinology & metabolism focusing on the menopause – Diagnostic and therapeutic strategies	14
The options for delayed surgery – Is there evidence available for delayed genitoplasty in differences/disorders of sex development?	14
Chemokines in thyroid autoimmunity	14
Genotype-phenotype correlations in Graves’ disease	14
Mortality in craniopharyngiomas: Data from the last two decades	14
Care quality improvement in differences of sex development	14
Addressing the social determinants of adverse outcomes in pregestational diabetes	13
COVID-induced thyroid autoimmunity	13
Preface	13
“Micromegaly”: Acromegaly with apparently normal GH, an entity on its own?	13